Westchester Capital Management (New York)’s Citius Oncology, Inc. Common Stock CTOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-300,000
| Closed | -$3.4M | – | 199 |
|
|
2024
Q2 | $3.4M | Hold |
300,000
| – | – | 0.13% | 86 |
|
|
2024
Q1 | $3.32M | Hold |
300,000
| – | – | 0.12% | 98 |
|
|
2023
Q4 | $3.29M | Hold |
300,000
| – | – | 0.12% | 105 |
|
|
2023
Q3 | $3.22M | Hold |
300,000
| – | – | 0.09% | 134 |
|
|
2023
Q2 | $3.16M | Hold |
300,000
| – | – | 0.1% | 161 |
|
|
2023
Q1 | $3.12M | Hold |
300,000
| – | – | 0.09% | 203 |
|
|
2022
Q4 | $3.05M | Buy |
+300,000
| New | +$3.05M | 0.08% | 232 |
|